Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2017 Filed Dec 19, 2017 00:52 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 340 | $43.70 | $14,858.00 |
DisclosureSEC source: 0001209191-17-066234 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,442 F1 · balance_after: Includes 719 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017. Read SEC document |
| November 20, 2017 Filed Nov 20, 2017 23:43 UTC |
Jones James BSVP & Chief Medical Officer
|
SaleCommon Stock | 850 | $41.11 | $34,942.48 |
DisclosureSEC source: 0001209191-17-061873 · doc4.xml · nonDerivative · entry 1 Jones James B · CIK 0001650857 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,823 F1 · balance_after: Includes 360 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,857 | $0.00 Strike: $25.37 | $0.00 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · derivative · entry 6 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,857 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
SaleCommon Stock | 7,857 | $40.00 | $314,280.00 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 4 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,312 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionCommon Stock | 7,857 | $25.37 | $199,332.09 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 3 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,143 | $0.00 Strike: $25.37 | $0.00 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · derivative · entry 5 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Underlying: Common Stock · 2,143 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
SaleCommon Stock | 2,143 | $40.01 | $85,741.43 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,312 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 23:44 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
Exercise / conversionCommon Stock | 2,143 | $25.37 | $54,367.91 |
DisclosureSEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:15 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,885 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-17-061557 · doc4.xml · derivative · entry 6 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,075 Underlying: Common Stock · 28,885 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:15 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 1,900 | $38.97 | $74,043.00 |
DisclosureSEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 3 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,279 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.10, inclusive. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:15 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 56,985 | $38.32 | $2,183,665.20 |
DisclosureSEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,179 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.80, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 17:15 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 28,885 | $1.61 | $46,504.85 |
DisclosureSEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| November 10, 2017 Filed Nov 14, 2017 01:03 UTC |
Kronenfeld Mark A.Director
|
PurchaseCommon Stock | 1,000 | $41.60 | $41,602.50 |
DisclosureSEC source: 0001209191-17-060479 · doc4.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,795 Read SEC document |
| August 22, 2017 Filed Aug 25, 2017 00:30 UTC |
HASTINGS PAUL JDirector
|
SaleCommon Stock | 1,044 | $36.15 | $37,740.60 |
DisclosureSEC source: 0001209191-17-050231 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,518 Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 22:56 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
SaleCommon Stock | 3,461 | $36.75 | $127,191.75 |
DisclosureSEC source: 0001209191-17-049503 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,312 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 18:55 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 28,885 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-17-049501 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,810 Underlying: Common Stock · 28,885 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 18:55 UTC |
STACK DAVID MDirector · CEO and Chairman
|
SaleCommon Stock | 28,885 | $36.37 | $1,050,547.45 |
DisclosureSEC source: 0001209191-17-049501 · doc4.xml · nonDerivative · entry 2 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,279 F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.90, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 18:55 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 28,885 | $1.61 | $46,504.85 |
DisclosureSEC source: 0001209191-17-049501 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| August 08, 2017 Filed Aug 16, 2017 20:43 UTC |
Froimson MarkDirector
|
PurchaseCommon Stock | 100 | $37.13 | $3,713.16 |
DisclosureSEC source: 0001209191-17-049323 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 17:28 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-17-046347 · doc4.xml · derivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,960 Underlying: Common Stock · 15,000 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 17:28 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $1.61 | $24,150.00 |
DisclosureSEC source: 0001209191-17-046347 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 220 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017. Read SEC document |
| June 23, 2017 Filed Jun 27, 2017 20:22 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001209191-17-042059 · doc4.xml · derivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,960 Underlying: Common Stock · 15,000 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months. Read SEC document |
| June 23, 2017 Filed Jun 27, 2017 20:22 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $1.61 | $24,150.00 |
DisclosureSEC source: 0001209191-17-042059 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:08 UTC |
Weiland Robert J.Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040685 · doc4.xml · derivative · entry 2 Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2027-06-14 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:08 UTC |
Weiland Robert J.Chief Commercial Officer
|
GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040685 · doc4.xml · nonDerivative · entry 1 Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. F2 · balance_after: Includes 364 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:06 UTC |
Scranton RichardChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040683 · doc4.xml · derivative · entry 2 Scranton Richard · CIK 0001709330 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:06 UTC |
Scranton RichardChief Scientific Officer
|
GrantCommon Stock | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040683 · doc4.xml · nonDerivative · entry 1 Scranton Richard · CIK 0001709330 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,593 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:12 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,144 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040688 · doc4.xml · derivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,144 Underlying: Common Stock · 8,144 shares Expires 2027-06-14 F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:01 UTC |
Braunstein ScottSVP, Strategy & Corp. Dev.
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040677 · doc4.xml · derivative · entry 3 Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2027-06-14 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:01 UTC |
Braunstein ScottSVP, Strategy & Corp. Dev.
|
GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040677 · doc4.xml · nonDerivative · entry 1 Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,982 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:04 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040679 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:04 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantCommon Stock | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040679 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:13 UTC |
Greenstreet YvonneDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040689 · doc4.xml · derivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:13 UTC |
Greenstreet YvonneDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040689 · doc4.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,845 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:10 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040686 · doc4.xml · derivative · entry 2 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:10 UTC |
WILLIAMS KRISTENCAO and General Counsel
|
GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040686 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,773 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC |
LONGENECKER JOHN P PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040692 · doc4.xml · derivative · entry 2 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:16 UTC |
LONGENECKER JOHN P PHDDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040692 · doc4.xml · nonDerivative · entry 1 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,145 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:18 UTC |
WINGER DENNIS LDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040694 · doc4.xml · derivative · entry 2 WINGER DENNIS L · CIK 0001222645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:18 UTC |
WINGER DENNIS LDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040694 · doc4.xml · nonDerivative · entry 1 WINGER DENNIS L · CIK 0001222645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,490 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:07 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 81,000 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040684 · doc4.xml · derivative · entry 4 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 81,000 shares Expires 2027-06-14 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:07 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantCommon Stock | 40,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040684 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,059 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:17 UTC |
PACE GARY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040693 · doc4.xml · derivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:17 UTC |
PACE GARY WDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040693 · doc4.xml · nonDerivative · entry 1 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,537 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:14 UTC |
HASTINGS PAUL JDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040690 · doc4.xml · derivative · entry 2 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:14 UTC |
HASTINGS PAUL JDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040690 · doc4.xml · nonDerivative · entry 1 HASTINGS PAUL J · CIK 0001309702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,562 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:11 UTC |
Brege LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040687 · doc4.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:11 UTC |
Brege LauraDirector
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040687 · doc4.xml · nonDerivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,845 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:15 UTC |
Kronenfeld Mark A.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,714 | $0.00 Strike: $44.20 | $0.00 |
DisclosureSEC source: 0001209191-17-040691 · doc4.xml · derivative · entry 2 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,714 Underlying: Common Stock · 2,714 shares Expires 2027-06-14 F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date. Read SEC document |
| June 14, 2017 Filed Jun 17, 2017 00:15 UTC |
Kronenfeld Mark A.Director
|
GrantCommon Stock | 1,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040691 · doc4.xml · nonDerivative · entry 1 Kronenfeld Mark A. · CIK 0001578074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,795 F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.